News

Anne Wojcicki is set to regain control of 23andMe after a $305 million bid from a nonprofit she controls topped Regeneron ...
23andMe struck a deal last month with Regeneron Pharmaceuticals Inc. but Wojcicki complained about the bidding process, ...
New York and 27 other states sued bankrupt genetic testing company 23andMe to block the sale of 15 million customers' ...
TTAM Commits to Comply with Company’s Privacy Policy and All Applicable Laws TTAM Commits to Adopting Additional Consumer Protections and Privacy Safeguards to Enhance Protections for Customer Data ...
House Democrats sent letters to the potential buyers of the genetic testing company, asking how they plan to protect customer ...
Me's Interim CEO Joe Selsavage said 1.9 million customers have asked the company delete their data since March.
Twenty-seven states and the District of Columbia took legal action this week against 23andMe in the U.S. Bankruptcy Court for ...
Regeneron Pharmaceuticals said on Monday it will buy genomics firm 23andMe Holding for $256 million through a bankruptcy ...
The future of the genetic data owned by 23andMe is uncertain as the company undergoes a court-supervised sale.
WilmerHale said it’s representing the law professor tapped to make privacy-related recommendations about the sale of ...
Me is proposing to reopen its bankruptcy auction to entertain a final offer from a nonprofit operated by its co-founder, ...
Anne Wojcicki is set to regain control of 23andMe after a nonprofit she controls topped Regeneron Pharmaceuticals' bid for ...